Cutter & Co Brokerage’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-36,465
| Closed | -$80.2K | – | 76 |
|
|
2025
Q1 | $80.2K | Buy |
36,465
+3,330
| +10% | +$7.33K | 0.02% | 175 |
|
|
2024
Q4 | $50.7K | Buy |
33,135
+13,600
| +70% | +$20.8K | 0.01% | 201 |
|
|
2024
Q3 | $38.9K | Buy |
+19,535
| New | +$38.9K | 0.01% | 208 |
|
|
2023
Q3 | – | Sell |
-10,180
| Closed | -$11.8K | – | 217 |
|
|
2023
Q2 | $11.8K | Sell |
10,180
-1,385
| -12% | -$1.61K | ﹤0.01% | 211 |
|
|
2023
Q1 | $17.5K | Sell |
11,565
-1,090
| -9% | -$1.65K | 0.01% | 214 |
|
|
2022
Q4 | $31.6K | Sell |
12,655
-250
| -2% | -$625 | 0.01% | 207 |
|
|
2022
Q3 | $54K | Sell |
12,905
-200
| -2% | -$837 | 0.02% | 213 |
|
|
2022
Q2 | $37K | Sell |
13,105
-275
| -2% | -$776 | 0.01% | 222 |
|
|
2022
Q1 | $77K | Sell |
13,380
-2,945
| -18% | -$16.9K | 0.02% | 221 |
|
|
2021
Q4 | $149K | Sell |
16,325
-14,510
| -47% | -$132K | 0.04% | 256 |
|
|
2021
Q3 | $330K | Buy |
30,835
+2,370
| +8% | +$25.4K | 0.08% | 199 |
|
|
2021
Q2 | $442K | Buy |
28,465
+625
| +2% | +$9.71K | 0.1% | 166 |
|
|
2021
Q1 | $451K | Sell |
27,840
-5,500
| -16% | -$89.1K | 0.11% | 161 |
|
|
2020
Q4 | $706K | Buy |
33,340
+2,860
| +9% | +$60.6K | 0.19% | 117 |
|
|
2020
Q3 | $452K | Buy |
30,480
+275
| +0.9% | +$4.08K | 0.13% | 136 |
|
|
2020
Q2 | $444K | Buy |
30,205
+480
| +2% | +$7.06K | 0.14% | 125 |
|
|
2020
Q1 | $349K | Buy |
29,725
+1,040
| +4% | +$12.2K | 0.13% | 136 |
|
|
2019
Q4 | $674K | Buy |
28,685
+6,175
| +27% | +$145K | 0.24% | 94 |
|
|
2019
Q3 | $416K | Buy |
22,510
+1,440
| +7% | +$26.6K | 0.13% | 166 |
|
|
2019
Q2 | $392K | Buy |
21,070
+6,415
| +44% | +$119K | 0.12% | 179 |
|
|
2019
Q1 | $358K | Buy |
14,655
+3,270
| +29% | +$79.9K | 0.1% | 179 |
|
|
2018
Q4 | $295K | Hold |
11,385
| – | – | 0.11% | 180 |
|
|
2018
Q3 | $360K | Hold |
11,385
| – | – | 0.12% | 161 |
|
|
2018
Q2 | $442K | Buy |
11,385
+765
| +7% | +$29.7K | 0.17% | 128 |
|
|
2018
Q1 | $293K | Buy |
+10,620
| New | +$293K | 0.12% | 173 |
|